Investor profile

Nueterra Capital logo

Nueterra Capital

Family office

USHealthtechAI/MLB2B SaaSFintechConsumer

See how your deck fits this investor's thesis, stage, and ticket size.

Analyse your fit

Investment thesis

Nueterra Capital is a Midwest-based venture capital firm specializing in early-stage healthcare and technology companies poised for rapid growth. The firm's strategy focuses on investments in technological solutions aimed at improving the administration, diagnosis, and delivery of healthcare — spanning concierge medicine, device and diagnostics, digital and consumer health, AI applications, and IT/software solutions including data interoperability, care coordination, revenue cycle management, and patient engagement. Nueterra places particular emphasis on U.S. Emerging Markets — regions outside traditional coastal economic hubs characterized by strong educational institutions, innovation, and business-friendly regulatory environments. The firm leverages over 25 years of operational experience managing 150+ surgery centers to identify clinical and administrative friction points, and offers portfolio companies the opportunity to pilot solutions within its own facilities, creating a proprietary diligence and deal-sourcing feedback loop.

Notable quotes

Nueterra Capital will focus on making investments in the healthcare companies and technologies that will truly advance the future of healthcare.

Dan Tasset · PR Newswire – NueHealth and Nueterra Capital press release · 2016-03-01

Between NueHealth and Nueterra Capital, we're going to give people access to care that they fully understand, we're going to create sustainable networks and facilities that keep physicians and health systems ahead of the healthcare evolution, and at the same time we're going to be investing in the very companies and ideas that will make the future of healthcare match our own vision.

Dan Tasset · PR Newswire – NueHealth and Nueterra Capital press release · 2016-03-01

I founded Nueterra Capital with the conviction that entrepreneurs—when paired with real operational expertise—would shape the future of healthcare. I believe venture capital, when grounded in execution and accountability, has the power to accelerate innovation, strengthen clinical models, and improve both outcomes and affordability for patients.

Dan Tasset · dantasset.com – founder biography

Team

Dan Tasset

Chairman

HealthtechB2B SaaSAI/ML

Jeremy Tasset

Chief Executive Officer

HealthtechB2B SaaSEnterprise

Emmanuel Emah-Emeni

Managing Director

HealthtechAI/MLFintech

George Lester

Senior Vice President

Healthtech

Travis Tasset

Investment Partner

HealthtechB2B SaaS

Brandon Tasset

Investment Partner

HealthtechB2B SaaS

Recent investments

CompanyRoundSizeDate
Kiddie KreditSeed$1m2023-04-19
MetriportSeed$2m2022-12-01
HealthJoySeries D$60m2022-10-01
Movn HealthSeries A2022-07-08
BrainCheckSeries B$10m2021-11-02
IVX HealthGrowth Equity$23m2019-08-05
BodilyVenture
medZEROVenture
WellBrainVenture
In2itive Business SolutionsVenture

Frequent co-investors

Fit check

Is Nueterra Capital a match for your startup?

Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.

Analyse your fit